Newsweek

Party Foul

Democrats are trying to be the party of #MeToo. But for all their commendable outrage over the Eric Schneiderman scandal, their grasp on moral superiority is also tenuous.
New York State Attorney General Eric Schneiderman speaks at a press conference announcing new guidelines and testing standards that GNC will adhere to for their herbal supplements and extracts on March 30, 2015 in New York City.
PER_MeToo_02_468142076

The headline said it all: “Four Women Accuse New York’s Attorney General of Physical Abuse.” At first, there was denial, talk of “role-playing” and vows of consensual sex. But just three hours later, Eric Schneiderman, a Democrat and prominent women’s advocate, was finished, brought down by in the latest #MeToo scandal. His party had demanded it. “The violent actions described by multiple women in this story are abhorrent,” said Senator Kirsten Gillibrand of New York. Describing their relationships with the attorney general, two of the women told the magazine he had slapped and choked them repeatedly. “Given the damning pattern of facts and corroboration laid out in the article, I do not believe it is possible for

You’re reading a preview, subscribe to read more.

More from Newsweek

Newsweek12 min read
The Inconceivable Search For Sperm
SINGLE WOMEN AND LGBTQ+ COUPLES are increasingly pursuing pregnancy via known donors—people they find on the internet, in Facebook groups and through dating-like apps. In her own quest to become a solo mother by choice, investigative journalist Valer
Newsweek3 min read
Newsweek US
GLOBAL EDITOR IN CHIEF _ Nancy Cooper VICE PRESIDENT, DIGITAL _ Laura Davis DIRECTOR OF OPERATIONS _ Melissa Jewsbury OPINION EDITOR _ Batya Ungar-Sargon GLOBAL PUBLISHING EDITOR _ Chris Roberts SENIOR EDITOR-AT-LARGE _ Josh Hammer EDITORIAL Managi
Newsweek5 min read
‘Deadly Risk’ of Fat-Loss Drugs
“MIRACLE” FAT-MELTING DRUG OZEMPIC HAS been linked in a study to a series of rare but potentially fatal psychiatric episodes, scientists have warned. The injectable prescription drug was developed to manage blood sugar levels in patients with Type 2

Related Books & Audiobooks